The Company is in the business of discovering, developing and commercializing small molecule drugs for the treatment of serious diseases.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
Vertex (VRTX) shares have been halted as an FDA advisory panel will review its telaprevir NDA today
7:05 am ET 04/28/2011-
Sounds like GOOD NEWS!
-- A Food and Drug Administration advisory panel unanimously recommended approval of Vertex Pharmaceuticals'(VRTX_) proposed hepatitis C drug on Thursday.
More on VRTX
Vertex: FDA Hep C Panel Live BlogTrading Of Vertex Common Stock Halted TodayMerck: FDA Hep C Panel Live BlogMarket Activity
Vertex Pharmaceuticals| VRTX UPThe Antiviral Drugs Advisory Committee voted 18-0 to recommend the FDA give a thumbs-up to Vertex's new drug application for telaprevir
Trading will resume tomorrow.